Project

An open, multicentric phase II trial to evaluate the efficacy and safety of Bendamustine, Lenalidomide (Revlimid®) and Dexamethasone (BRd) as 2nd-line therapy for patients with relapsed or refractory multiple myeloma

Automatically Closed · 2012 until 2014

Driessen Christoph, Mey Ulrich, Hiendlmeyer Elke, Clavadetscher Luzia